News
U.S. Advises Older Travelers to Avoid Chikungunya Vaccine
TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible side effects. The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) issued the warning late last week.
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...
A vaccine designed to protect against chikungunya, a mosquito-borne illness, has been temporarily paused for individuals aged 60 and older.
The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...
FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...
The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into reports of possible side effects.
1don MSN
Most stories of chikungunya begin with something oddly harmless — a slight twitch in the toes or fingers. That’s when the ...
Reports of severe adverse events in some people who received the chikungunya vaccine have spurred regulators in Europe and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback